Print page   E-mail page   Download PDF   
« Previous Release | Next Release »

Warner Chilcott to Present at the UBS Global Life Sciences Conference

DUBLIN, Ireland, Sept. 13, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the UBS Global Life Sciences Conference on Monday, September 19th at 1:30 p.m. EDT.

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

CONTACT:  Emily Hill

          Investor Relations

          973-907-7084

          Emily.Hill@wcrx.com

Close window | Back to top